Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Jennifer Dien Bard, PhD, D(ABMM), FIDSA, FAAM (she/her/hers)

Chief of Clinical Operations, Director of Clinical Microbiology and Virology
Children's Hospital Los Angeles; University of Southern California

Jennifer Dien Bard, PhD, D(ABMM), FIDSA, FAAM is a Professor of Pathology (Clinical Scholar) in the Department of Pathology, Keck School of Medicine, University of Southern California. She is the Chief of Clinical Operations and Director of the Clinical Microbiology and Virology Laboratories in the Department of Pathology and Laboratory Medicine at Children’s Hospital Los Angeles. Dr. Dien Bard has served on several committees and working groups for organizations including the National Academy of Science (NAS), the Infectious Diseases Society of America (IDSA), the Association for Molecular Pathology (AMP), the American Society for Microbiology (ASM), the Clinical and Laboratory Standards Institute (CLSI) and the Antimicrobial Resistance Leadership Group (ARLG). Dr. Dien Bard is an Editor for the Journal of Clinical Microbiology, and an Associate Editor for the Journal of Clinical Virology. Dr. Dien Bard has published over 100 scientific papers and her clinical research studies explore the application and effects of laboratory diagnostic, particularly molecular diagnostics and antimicrobial susceptibility testing, on patient diagnosis, antimicrobial utilization and overall clinical outcome.

Disclosure(s): Abbott Molecular Inc: Grant/Research Support (Terminated); Becton, Dickinson and Company (BD): Advisor/Consultant (Ongoing); bioMerieux Inc.: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Cepheid, Inc: Grant/Research Support (Ongoing); Diasorin Molecular LLC: Grant/Research Support (Ongoing); Genetic Signatures: Advisor/Consultant (Terminated), Grant/Research Support (Terminated); Hologic: Grant/Research Support (Ongoing); Luminex: Grant/Research Support (Ongoing); Thermo Fisher: Honoraria (Ongoing)

Presentation(s):